Evidence map›Paper›PMID 22748660›Full record

ReviewNeurosurgery clinics of North America2012

Passive immunotherapeutic strategies for the treatment of malignant gliomas.

Daniel T Nagasawa, Christina Fong, Andrew Yew, Marko Spasic, Heather M Garcia, Carol A Kruse, Isaac Yang

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Neurosurgery clinics of North America, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Receptor-Targeted Glial Brain Tumor Therapies.International journal of molecular sciences · 2018
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Daniel T NagasawaDepartment of Neurosurgery, University of California Los Angeles, Los Angeles, CA 90095-1761, USA.
Christina Fong
Andrew Yew
Marko Spasic
Heather M Garcia
Carol A Kruse
Isaac Yang
University of California, Los Angeles · US

Funding

Adoptive Transfer of AlloCTL for Immunotherapy of Recurrent GliomasR01CA125244 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KRUSE, CAROL A, LIAU, LINDA M · 2010 to 2014
$2.4M
Cellular Transduction with Replication-Competent Retrovirus VectorsR01CA121258 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KASAHARA, NORIYUKI · 2007 to 2011
$2.3M
Optimizing Induction Conditions for Immunotherapeutic CTLR01CA154256 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI PRINS, ROBERT M · 2010 to 2014
$1.9M
NCI NIH HHS R01 CA121258NCI NIH HHS R01CA121258NCI NIH HHS R01 CA125244NCI NIH HHS R01CA125244NCI NIH HHS R01 CA154256NCI NIH HHS R01CA154256
6 · The paper itself

Abstract

This review provides historical and recent perspectives related to passive immunotherapy for high-grade gliomas. The authors discuss approaches that use lymphokine-activated killer cells, cytotoxic T lymphocytes, and monoclonal antibodies.

Indexed as

Antibodies, MonoclonalBrain NeoplasmsCytokine-Induced Killer CellsGlioblastomaHumansImmunization, PassiveImmunotherapy, AdoptiveRadioimmunotherapyT-Lymphocytes, CytotoxicTumor EscapeAntibodies, Monoclonal

Identifiers

PMID22748660
PMCPMC3994467
OpenAlexW2130618984

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.